North Star Investment Management Corp. Amgen Inc Transaction History

North Star Investment Management Corp.

$1.35 Billion
Q1 2025

A detailed history of North Star Investment Management Corp. transactions in Amgen Inc stock. As of the latest transaction made, North Star Investment Management Corp. holds 23,153 shares of AMGN stock, worth $6.5 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

23,153

Previous 24,423 5.2%

Holding current value

$6.5 Million

Previous $6.37 Million 13.32%

% of portfolio

0.53%

Previous 0.45%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	SELL	$258.59 - $327.36 $328,409 - $415,747	-1,270 Reduced 5.2%	23,153 $7.21 Million
Q4 2024 Feb 10, 2025	SELL	$258.78 - $328.31 $197,190 - $250,172	-762 Reduced 3.03%	24,423 $6.37 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $110,758 - $120,782	-358 Reduced 1.4%	25,185 $8.11 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $81,452 - $98,986	-310 Reduced 1.2%	25,543 $7.98 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $378,031 - $456,331	1,406 Added 5.75%	25,853 $7.35 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $3,579 - $4,038	-14 Reduced 0.06%	24,447 $7.04 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $46,353 - $57,549	212 Added 0.87%	24,461 $6.57 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $4,928 - $5,827	23 Added 0.09%	24,249 $5.38 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $659,984 - $804,409	2,923 Added 13.72%	24,226 $5.86 Million
Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $10,306 - $13,095	45 Added 0.21%	21,303 $0
Q3 2022 Nov 02, 2022	SELL	$224.46 - $253.15 $22,670 - $25,568	-101 Reduced 0.47%	21,258 $4.79 Million
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $4,383 - $4,878	19 Added 0.09%	21,359 $5.2 Million
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $226,286 - $250,332	-1,032 Reduced 4.61%	21,340 $5.16 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $218,569 - $250,132	1,099 Added 5.17%	22,372 $5.03 Million
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $4,033 - $4,725	19 Added 0.09%	21,273 $4.52 Million
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $5,372 - $5,960	-23 Reduced 0.11%	21,254 $5.18 Million
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $111,176 - $129,558	-501 Reduced 2.3%	21,277 $5.29 Million
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $41,977 - $49,987	-194 Reduced 0.88%	21,778 $5.01 Million
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $3,285 - $3,653	14 Added 0.06%	21,972 $5.59 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $91,783 - $112,631	-464 Reduced 2.07%	21,958 $5.18 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $114,628 - $152,029	-629 Reduced 2.73%	22,422 $4.55 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $3,027 - $3,891	16 Added 0.07%	23,051 $5.56 Million
Q3 2019 Oct 03, 2019	SELL	$174.11 - $208.62 $12,710 - $15,229	-73 Reduced 0.32%	23,035 $4.46 Million
Q2 2019 Jul 15, 2019	BUY	$166.7 - $195.41 $1,667 - $1,954	10 Added 0.04%	23,108 $4.26 Million
Q1 2019 Apr 10, 2019	SELL	$180.87 - $203.88 $312,724 - $352,508	-1,729 Reduced 6.96%	23,098 $4.39 Million
Q4 2018 Jan 07, 2019	SELL	$178.4 - $208.25 $38,891 - $45,398	-218 Reduced 0.87%	24,827 $4.83 Million
Q3 2018 Oct 11, 2018	SELL	$185.29 - $208.89 $19,640 - $22,142	-106 Reduced 0.42%	25,045 $5.19 Million
Q2 2018 Jul 20, 2018	SELL	$166.05 - $186.51 $7,804 - $8,765	-47 Reduced 0.19%	25,151 $4.64 Million
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $37,105 - $43,362	219 Added 0.88%	25,198 $4.3 Million
Q4 2017 Jan 11, 2018	SELL	$168.79 - $188.59 $42,197 - $47,147	-250 Reduced 0.99%	24,979 $4.34 Million
Q3 2017 Oct 06, 2017	BUY	$167.29 - $191.0 $4.22 Million - $4.82 Million	25,229	25,229 $4.7 Million

Others Institutions Holding AMGN

# of Institutions

3,234

Shares Held

422M

Call Options Held

7.05M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.

Account

North Star Investment Management Corp. Amgen Inc Transaction History